Consent of Proposed DirectorConsent of Proposed Director • August 12th, 2020 • AMERI Holdings, Inc. • Semiconductors & related devices
● to serve as a director of the Resulting Issuer (as defined herein) if the transactions contemplated by the tender agreement, dated August 12, 2020 (as may be amended, the “Tender Agreement”), by and among AMERI Holdings, Inc. (“Ameri”, and after giving effect to the consummation of the transactions contemplated by the Tender Agreement, the “Resulting Issuer”) and Jay Pharma Inc. (“Jay Pharma”) are completed (it being understood that the Tender Agreement provides that, among other things, Ameri will make a tender offer (such offer, as it may be amended or supplemented from time to time as permitted under the Tender Agreement, the “Offer”) to purchase all of the outstanding common shares of Jay Pharma for the number of shares of Resulting Issuer common stock equal to the exchange ratio set forth in the Tender Agreement, and Jay Pharma will become a wholly-owned subsidiary of Ameri, on the terms and conditions set forth in the Tender Agreement);
Consent of Proposed DirectorConsent of Proposed Director • November 7th, 2007 • Echo Healthcare Acquisition Corp. • Agricultural services
The undersigned hereby consents to serve as a director of Echo Healthcare Acquisition Corp. (“Echo”) if the Second Amended and Restated Agreement and Plan of Merger (the “Merger Agreement”), dated as of October 23, 2007, by and among Echo, Pet DRx Acquisition Company, Echo’s wholly-owned subsidiary, and XLNT Veterinary Care, Inc., and the transactions contemplated by the Merger Agreement, are consummated, and to be named as a potential director of Echo in the Registration Statement on Form S-4 related to the merger agreement.
Consent of Proposed DirectorConsent of Proposed Director • August 12th, 2020 • AMERI Holdings, Inc. • Semiconductors & related devices
● to serve as a director of the Resulting Issuer (as defined herein) if the transactions contemplated by the tender agreement, dated August 12, 2020 (as may be amended, the “Tender Agreement”), by and among AMERI Holdings, Inc. (“Ameri”, and after giving effect to the consummation of the transactions contemplated by the Tender Agreement, the “Resulting Issuer”) and Jay Pharma Inc. (“Jay Pharma”) are completed (it being understood that the Tender Agreement provides that, among other things, Ameri will make a tender offer (such offer, as it may be amended or supplemented from time to time as permitted under the Tender Agreement, the “Offer”) to purchase all of the outstanding common shares of Jay Pharma for the number of shares of Resulting Issuer common stock equal to the exchange ratio set forth in the Tender Agreement, and Jay Pharma will become a wholly-owned subsidiary of Ameri, on the terms and conditions set forth in the Tender Agreement);
Consent of Proposed DirectorConsent of Proposed Director • November 7th, 2007 • Echo Healthcare Acquisition Corp. • Agricultural services
The undersigned hereby consents to serve as a director of Echo Healthcare Acquisition Corp. (“Echo”) if the Second Amended and Restated Agreement and Plan of Merger (the “Merger Agreement”), dated as of October 23, 2007, by and among Echo, Pet DRx Acquisition Company, Echo’s wholly-owned subsidiary, and XLNT Veterinary Care, Inc., and the transactions contemplated by the Merger Agreement, are consummated, and to be named as a potential director of Echo in the Registration Statement on Form S-4 related to the merger agreement.
Consent of Proposed DirectorConsent of Proposed Director • August 12th, 2020 • AMERI Holdings, Inc. • Semiconductors & related devices
● to serve as a director of the Resulting Issuer (as defined herein) if the transactions contemplated by the tender agreement, dated August 12, 2020 (as may be amended, the “Tender Agreement”), by and among AMERI Holdings, Inc. (“Ameri”, and after giving effect to the consummation of the transactions contemplated by the Tender Agreement, the “Resulting Issuer”) and Jay Pharma Inc. (“Jay Pharma”) are completed (it being understood that the Tender Agreement provides that, among other things, Ameri will make a tender offer (such offer, as it may be amended or supplemented from time to time as permitted under the Tender Agreement, the “Offer”) to purchase all of the outstanding common shares of Jay Pharma for the number of shares of Resulting Issuer common stock equal to the exchange ratio set forth in the Tender Agreement, and Jay Pharma will become a wholly-owned subsidiary of Ameri, on the terms and conditions set forth in the Tender Agreement);
Consent of Proposed DirectorConsent of Proposed Director • May 28th, 2020 • AMERI Holdings, Inc. • Semiconductors & related devices
● to serve as a director of the Resulting Issuer (as defined herein) if the transactions contemplated by the Amalgamation Agreement, dated January 10, 2020 (as amended on May 6, 2020 and May 26, 2020 and as may be further amended, the “Amalgamation Agreement”), by and among AMERI Holdings, Inc. (“Ameri”, and after giving effect to the Amalgamation and the consummation of the transactions contemplated by the Amalgamation Agreement, the “Resulting Issuer”), Jay Pharma Merger Sub, Inc., a wholly owned subsidiary of Ameri (“Merger Sub”), Jay Pharma Inc. (“Jay Pharma”), 1236567 B.C. Unlimited Liability Company (“ExchangeCo”) and Barry Kostiner are consummated, including the amalgamation of Merger Sub and Jay Pharma into one corporation to continue as a direct wholly-owned subsidiary of ExchangeCo and an indirect wholly-owned subsidiary of Ameri (collectively, the “Amalgamation”);
Consent of Proposed DirectorConsent of Proposed Director • November 7th, 2007 • Echo Healthcare Acquisition Corp. • Agricultural services
The undersigned hereby consents to serve as a director of Echo Healthcare Acquisition Corp. (“Echo”) if the Second Amended and Restated Agreement and Plan of Merger (the “Merger Agreement”), dated as of October 23, 2007, by and among Echo, Pet DRx Acquisition Company, Echo’s wholly-owned subsidiary, and XLNT Veterinary Care, Inc., and the transactions contemplated by the Merger Agreement, are consummated, and to be named as a potential director of Echo in the Registration Statement on Form S-4 related to the merger agreement.
Consent of Proposed DirectorConsent of Proposed Director • November 7th, 2007 • Echo Healthcare Acquisition Corp. • Agricultural services
The undersigned hereby consents to serve as a director of Echo Healthcare Acquisition Corp. (“Echo”) if the Second Amended and Restated Agreement and Plan of Merger (the “Merger Agreement”), dated as of October 23, 2007, by and among Echo, Pet DRx Acquisition Company, Echo’s wholly-owned subsidiary, and XLNT Veterinary Care, Inc., and the transactions contemplated by the Merger Agreement, are consummated, and to be named as a potential director of Echo in the Registration Statement on Form S-4 related to the merger agreement.
Consent of Proposed DirectorConsent of Proposed Director • August 12th, 2020 • AMERI Holdings, Inc. • Semiconductors & related devices
● to serve as a director of the Resulting Issuer (as defined herein) if the transactions contemplated by the tender agreement, dated August 12, 2020 (as may be amended, the “Tender Agreement”), by and among AMERI Holdings, Inc. (“Ameri”, and after giving effect to the consummation of the transactions contemplated by the Tender Agreement, the “Resulting Issuer”) and Jay Pharma Inc. (“Jay Pharma”) are completed (it being understood that the Tender Agreement provides that, among other things, Ameri will make a tender offer (such offer, as it may be amended or supplemented from time to time as permitted under the Tender Agreement, the “Offer”) to purchase all of the outstanding common shares of Jay Pharma for the number of shares of Resulting Issuer common stock equal to the exchange ratio set forth in the Tender Agreement, and Jay Pharma will become a wholly-owned subsidiary of Ameri, on the terms and conditions set forth in the Tender Agreement);
Consent of Proposed DirectorConsent of Proposed Director • November 7th, 2007 • Echo Healthcare Acquisition Corp. • Agricultural services
The undersigned hereby consents to serve as a director of Echo Healthcare Acquisition Corp. (“Echo”) if the Second Amended and Restated Agreement and Plan of Merger (the “Merger Agreement”), dated as of October 23, 2007, by and among Echo, Pet DRx Acquisition Company, Echo’s wholly-owned subsidiary, and XLNT Veterinary Care, Inc., and the transactions contemplated by the Merger Agreement, are consummated, and to be named as a potential director of Echo in the Registration Statement on Form S-4 related to the merger agreement.
Consent of Proposed DirectorConsent of Proposed Director • November 7th, 2007 • Echo Healthcare Acquisition Corp. • Agricultural services
The undersigned hereby consents to serve as a director of Echo Healthcare Acquisition Corp. (“Echo”) if the Second Amended and Restated Agreement and Plan of Merger (the “Merger Agreement”), dated as of October 23, 2007, by and among Echo, Pet DRx Acquisition Company, Echo’s wholly-owned subsidiary, and XLNT Veterinary Care, Inc., and the transactions contemplated by the Merger Agreement, are consummated, and to be named as a potential director of Echo in the Registration Statement on Form S-4 related to the merger agreement.
Consent of Proposed DirectorConsent of Proposed Director • November 7th, 2007 • Echo Healthcare Acquisition Corp. • Agricultural services
The undersigned hereby consents to serve as a director of Echo Healthcare Acquisition Corp. (“Echo”) if the Second Amended and Restated Agreement and Plan of Merger (the “Merger Agreement”), dated as of October 23, 2007, by and among Echo, Pet DRx Acquisition Company, Echo’s wholly-owned subsidiary, and XLNT Veterinary Care, Inc., and the transactions contemplated by the Merger Agreement, are consummated, and to be named as a potential director of Echo in the Registration Statement on Form S-4 related to the merger agreement.
Consent of Proposed DirectorConsent of Proposed Director • May 12th, 2008 • Granahan McCourt Acquisition CORP • Blank checks
The undersigned hereby consents to serve as a director of Granahan McCourt Acquisition Corporation (the "Corporation") if the Agreement and Plan of Merger (the "Merger Agreement"), by and among Satellite Merger Corp., a Georgia corporation ("Merger Sub"), the Corporation, Pro Brand International, Inc., a Georgia corporation ("PBI"), and each of the equityholders of PBI listed therein, and the transactions contemplated by the Merger Agreement, are consummated, and to be named as a potential director of the Corporation in the Registration Statement on Form S-4 related to the Merger Agreement.
Consent of Proposed DirectorConsent of Proposed Director • May 12th, 2008 • Granahan McCourt Acquisition CORP • Blank checks
The undersigned hereby consents to serve as a director of Granahan McCourt Acquisition Corporation (the "Corporation") if the Agreement and Plan of Merger (the "Merger Agreement"), by and among Satellite Merger Corp., a Georgia corporation ("Merger Sub"), the Corporation, Pro Brand International, Inc., a Georgia corporation ("PBI"), and each of the equityholders of PBI listed therein, and the transactions contemplated by the Merger Agreement, are consummated, and to be named as a potential director of the Corporation in the Registration Statement on Form S-4 related to the Merger Agreement.
Consent of Proposed DirectorConsent of Proposed Director • November 7th, 2007 • Echo Healthcare Acquisition Corp. • Agricultural services
The undersigned hereby consents to serve as a director of Echo Healthcare Acquisition Corp. (“Echo”) if the Second Amended and Restated Agreement and Plan of Merger (the “Merger Agreement”), dated as of October 23, 2007, by and among Echo, Pet DRx Acquisition Company, Echo’s wholly-owned subsidiary, and XLNT Veterinary Care, Inc., and the transactions contemplated by the Merger Agreement, are consummated, and to be named as a potential director of Echo in the Registration Statement on Form S-4 related to the merger agreement.
Consent of Proposed DirectorConsent of Proposed Director • August 12th, 2020 • AMERI Holdings, Inc. • Semiconductors & related devices
● to serve as a director of the Resulting Issuer (as defined herein) if the transactions contemplated by the tender agreement, dated August 12, 2020 (as may be amended, the “Tender Agreement”), by and among AMERI Holdings, Inc. (“Ameri”, and after giving effect to the consummation of the transactions contemplated by the Tender Agreement, the “Resulting Issuer”) and Jay Pharma Inc. (“Jay Pharma”) are completed (it being understood that the Tender Agreement provides that, among other things, Ameri will make a tender offer (such offer, as it may be amended or supplemented from time to time as permitted under the Tender Agreement, the “Offer”) to purchase all of the outstanding common shares of Jay Pharma for the number of shares of Resulting Issuer common stock equal to the exchange ratio set forth in the Tender Agreement, and Jay Pharma will become a wholly-owned subsidiary of Ameri, on the terms and conditions set forth in the Tender Agreement);
